A Feasibility Phase II Study of Gemcitabine With Docetaxel With Concurrent 3-D Conformal Radiation Plus Continuous Infusion 5-Fluorouracil in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers
To assess the feasibility of administering induction chemotherapy with gemcitabine and
docetaxel followed by concurrent radiation and continuous infusion 5FU and consolidation
gemcitabine/docetaxel chemotherapy.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To assess the feasibility of administering induction chemotherapy with gemcitabine and docetaxel followed by concurrent radiation and continuous infusion 5FU and consolidation gemcitabine/docetaxel chemotherapy.
throughout trial participation
No
Benjamin Tan, M.D.
Principal Investigator
Washington University School of Medicine
United States: Institutional Review Board
02-0580 / 201101866
NCT00660699
September 2002
September 2012
Name | Location |
---|---|
Washington University School of Medicine | Saint Louis, Missouri 63110 |